0001104659-24-068733.txt : 20240605 0001104659-24-068733.hdr.sgml : 20240605 20240605171542 ACCESSION NUMBER: 0001104659-24-068733 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240601 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240605 DATE AS OF CHANGE: 20240605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Entero Therapeutics, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464993860 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37853 FILM NUMBER: 241022998 BUSINESS ADDRESS: STREET 1: 777 YAMATO ROAD STREET 2: SUITE 502 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 561-589-7020 MAIL ADDRESS: STREET 1: 777 YAMATO ROAD STREET 2: SUITE 502 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: First Wave BioPharma, Inc. DATE OF NAME CHANGE: 20210921 FORMER COMPANY: FORMER CONFORMED NAME: AzurRx BioPharma, Inc. DATE OF NAME CHANGE: 20141103 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 8-K 1 tm2416518d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 1, 2024

	Entero Therapeutics, Inc.
	(Exact name of registrant as specified in its charter)

Delaware		001-37853		46-4993860
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

777 Yamato Road, Suite 502

Boca Raton, Florida

33431

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (561) 589-7020

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ENTO		Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 4.01

Change in Registrant’s Certifying Accountant

Entero Therapeutics, Inc. (the “Company”) was notified that Mazars USA LLP (“Mazars”), the Company’s independent registered public accounting firm, entered into a transaction with FORVIS, LLP (“FORVIS”) whereby substantially all of the partners and employees of Mazars joined FORVIS. As a result, on the effective date of June 1, 2024, FORVIS, LLP changed its name to Forvis Mazars, LLP (“Forvis Mazars”) and Mazars resigned as the Company’s independent public accounting firm. The Audit Committee of the Company’s Board of Directors has appointed Forvis Mazars to serve as the Company’s independent registered public accounting firm effective June 1, 2024, subject to ratification by the Company’s stockholders at the Company’s annual meeting of stockholders.

The audit reports of Mazars on the financial statements of the Company for the fiscal years ended December 31, 2023 and 2022 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles.

During the Company’s fiscal years ended December 31, 2023 and 2022, and the subsequent interim period preceding the engagement of Forvis Mazars, there were no disagreements between the Company and Mazars on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Mazars, would have cause Mazars to make reference to any subject matter of the disagreements in connection with its audit reports on the Company’s financial statements. During the Company’s previous fiscal years ended December 31, 2023 and 2022, and the interim period through the engagement of Forvis Mazars, Mazars did not advise the Company of any matters specified in Item 304(a)(1)(v) of Regulation S-K.

The Company has requested that Mazars, review the disclosures contained in this report and has asked Mazars to furnish it with a currently dated letter addressed to the Securities and Exchange Commission containing any new information, clarification of the Company’s expression of its views or the respects in which it does not agree with the statements made by the Company in response to Item 304(a) of Regulation S-K. A copy of such letter is filed as Exhibit 16.1 to this Current Report on Form 8-K.

During the Company’s two most recently completed fiscal years and through the date of engagement of Forvis Mazars, neither the Company nor anyone on behalf of the Company consulted with Mazars regarding (a) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements as to which the Company received a written report or oral advice that was an important factor in reaching a decision on any accounting, auditing or financial reporting issue; or (b) any matter that was the subject of a disagreement or a reportable event as defined in Items 304(a)(1)(iv) and (v), respectively, of Regulation S-K. During the Company’s fiscal years ended December 31, 2023 and 2022, and the subsequent period through the date of this Current Report on Form 8-K, the Company did not consult with Forvis Mazars regarding any of the matters set forth in Items 304(a)(2)(i) and (ii) of Regulation S-K.

Item 9.01

Financial Statements and Exhibits.

(d)	Exhibits.

The following Exhibits are being filed with this Current Report on Form 8-K.

Exhibit No.	Description
16.1	Letter, dated June 5, 2024, from Mazars USA, LLP to the U.S. Securities and Exchange Commission.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Entero Therapeutics, Inc.

June 5, 2024	By:	/s/ James Sapirstein
	Name:	James Sapirstein
	Title:	Chief Executive Officer

EX-16.1 2 tm2416518d1_ex16-1.htm EXHIBIT 16.1

Exhibit 16.1

June 5, 2024

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Ladies and Gentlemen:

We have read Item 4.01 of Form 8-K dated June 5, 2024 of Entero Threapeutics, Inc. and are in agreement with the statements therein concerning Mazars USA LLP. We have no basis to agree or disagree with other statements of the registrant contained therein.

/s/ Mazars USA LLP

New York, NY

EX-101.SCH 3 fwbi-20240601.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 fwbi-20240601_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 fwbi-20240601_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	Jun. 01, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Jun. 01, 2024
Entity File Number	001-37853
Entity Registrant Name	Entero Therapeutics, Inc.
Entity Central Index Key	0001604191
Entity Tax Identification Number	46-4993860
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	777 Yamato Road
Entity Address, Address Line Two	Suite 502
Entity Address, City or Town	Boca Raton
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33431
City Area Code	561
Local Phone Number	589-7020
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	ENTO
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://firstwavebio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports fwbi-20240601.xsd fwbi-20240601_lab.xml fwbi-20240601_pre.xml tm2416518d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2416518d1_8k.htm": { "nsprefix": "FWBI", "nsuri": "http://firstwavebio.com/20240601", "dts": { "schema": { "local": [ "fwbi-20240601.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "fwbi-20240601_lab.xml" ] }, "presentationLink": { "local": [ "fwbi-20240601_pre.xml" ] }, "inline": { "local": [ "tm2416518d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://firstwavebio.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-06-01", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2416518d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-06-01", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2416518d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://firstwavebio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001104659-24-068733-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-068733-xbrl.zip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end XML 17 tm2416518d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001604191 2024-06-01 2024-06-01 iso4217:USD shares iso4217:USD shares false 0001604191 8-K 2024-06-01 Entero Therapeutics, Inc. DE 001-37853 46-4993860 777 Yamato Road Suite 502 Boca Raton FL 33431 561 589-7020 false false false false Common Stock, par value $0.0001 per share ENTO NASDAQ false